A canceled bond’s potential shares are excluded as Medirom (MRM) holders report their stakes.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Triple One Investment Partnership, Kabushiki Kaisha CARPE DIEM, and Takao Shimura have each reported a beneficial ownership of 66,540 shares, representing 0.8% of Medirom Healthcare Technologies Inc. (MRM). This percentage is calculated based on 7,901,950 outstanding common shares, specifically excluding any shares that would have been issuable upon the conversion of a recently canceled convertible bond.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.